SLC6A3 and Cognitive impairment: Compared to other risk factors for α-synucleinopathy, such as cognitive deficits, olfactory impairment and dopamine transporter protein (DAT-SPECT) abnormalities are at much higher predicted risk in the conversion of iRBD to α-synucleinopathy.